PLOS Computational Biology, 2025 Putting computational models of immunity to the test—An invited challenge to predict B.pertussis vaccination responses Shinde P., Willemsen L., Anderson M. et al. Olink Target 96Infectious DiseasesTechnical EvaluationPlasma | | | | |
PLOS Neglected Tropical Diseases, 2025 Transcriptional and cytokine signatures of Mycobacterium abscessus complex pulmonary disease during disease progression and treatment Syenina A., Tan Y., Tng D. et al. Olink Target 48Respiratory DiseasesInfectious DiseasesPatient StratificationPlasma | | | | |
Brain, Behavior, and Immunity, 2025 CCL25 in the cerebrospinal fluid is negatively correlated with fatigue in chronic pain patients Rosenström A., Ahmed A., Farinotti A. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasmaCSF | | | | |
BMC Medical Genomics, 2025 Causal association between non-steroidal anti-inflammatory drugs use and the risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study Peng Z., Li M., He M. et al. Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma | | | | |
Clinical, Cosmetic and Investigational Dermatology, 2025 Mendelian Randomization Analysis Supports a Causal Relationship Between Circulating Inflammatory Proteins and Basal Cell Carcinoma Fu Z., Wang Y., Yan H. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Clinical and Translational Medicine, 2025 Sendotypes predict worsening renal function in chronic kidney disease patients McLarnon T., Watterson S., McCallion S. et al. Olink Target 96NephrologyAgingPatient StratificationPlasma | | | | |
Rheumatology, 2025 Trans-omics landscape of systemic vasculitis identified matrix metalloproteinase 12 as a novel signature molecule Matsumoto K., Suzuki K., Magi M. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum | | | | |
International Journal of Molecular Sciences, 2025 The Presence of Adipose Tissue in Aortic Valves Influences Inflammation and Extracellular Matrix Composition in Chronic Aortic Regurgitation Sádaba A., Garaikoetxea M., Tiraplegui C. et al. Olink Target 96CVDPathophysiologyTissue Lysate | | | | |
Journal of Virology, 2025 Development and optimization of human T-cell leukemia virus-specific antibody-dependent cell-mediated cytotoxicity (ADCC) assay directed to the envelope protein Pise-Masison C., Rahman M., Masison D. et al. Olink Target 48Infectious DiseasesTechnical EvaluationPrimate Plasma | | | | |
Cancer Immunology, Immunotherapy, 2025 DNA methylation-regulated HLA-C expression modulates immune responses and metabolic alterations to influence prognosis in mesothelioma Zhang H., Yu L., Guo Y. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
ASAIO Journal, 2025 Candidate Biomarkers YES1, Troponin I, Lactate, and Ammonia for Evaluation of Cardiac Function Post Hypothermic Oxygenated Perfusion Ballan E., Vervoorn M., Kaffka genaamd Dengler S. et al. Olink Target 96CVDPathophysiologyPig Heart Perfusate | | | | |
Frontiers in Pharmacology, 2025 Cardiorenal protective effects of Tanhuo decoction in acute myocardial infarction via regulating multi-target inflammation and metabolic signaling pathways Guo C., Zhang T., He L. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Autoimmunity, 2025 Unveiling causal pathways in autoimmune diseases: a multi-omics approach Sha H., Zhu W. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Nature Communications, 2025 Modifiable risk factors and plasma proteomics in relation to complications of type 2 diabetes Li R., Tian S., Liu J. et al. Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma | | | | |
Scientific Reports, 2025 Deciphering genetic causality between plasma BDNF and 91 circulating inflammatory proteins through bidirectional mendelian randomization Sun Y., Shi X., Ohm M. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Immunity, 2025 Single-cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 signaling in ALS pathogenesis Zelic M., Blazier A., Pontarelli F. et al. Olink Explore 3072/384NeurologyPathophysiologyCell Culture Supernatant | | | | |
Neuro-Oncology, 2025 A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma Wen P., Manzanera A., Duault C. et al. Olink Target 48OncologyImmunotherapyPathophysiologyPlasma | | | | |
Clinical Biochemistry, 2025 Vascular endothelial growth factor A, a potential non-invasive biomarker for metabolic dysfunction-associated steatotic liver disease progression Jönsson C., Ma’ayeh S., Zhang B. et al. Olink Target 96HepatologyPatient StratificationPlasma | | | | |
JHLT Open, 2025 Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantation Qayyum A., Lund T., Jensen P. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
The Journal of Headache and Pain, 2025 Uncovering drug targets for cluster headache through proteome-wide Mendelian randomization analysis Xiong Z., Guo Z., Zhao L. et al. Olink Explore 3072/384NeurologyPathophysiologyPlasma | | | | |